The Unlikely Union of Bard and Bainbridge
CR Bard bought Bainbridge Sciences three years ago as part of an effort to expand the portfolio of its highly regarded urology franchise into high tech, high margin areas. Proponents saw it as an opportunity to get Bard Urological division moving again. Opponents wondered what the device company wanted in a complex business it didn't know anything about.
You may also be interested in...
The US FDA released five device-related close-out letters in March.
Governments around the world should designate all medicines as ‘priority essential products’, the IGBA has urged, as a surge in demand coinciding with a reduction in the number of flights and rising freight costs are making it more difficult for suppliers to meet global requirements amid the coronavirus pandemic.
In a letter to the medtech industry, the FDA’s William Maisel says the US agency will hold remote meetings with device makers and other stakeholders through the end of May. The FDA also extended due dates for marketing applications by 90 days.